Assess the Oral Bioavailability of New ABT-263 Formulations

Clinical trial NCT00743028 · COMPLETED

Trial details

NCT number: NCT00743028
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Lymphomas Leukemias

Start date: 2008-08-01
Primary completion: 2010-08-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.